| 1 |
3D HNCO |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 2 |
3D HNCA |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 3 |
3D CBCA(CO)NH |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 4 |
3D HCCH-TOCSY |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 5 |
3D HCCH-TOCSY |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 6 |
3D 1H-15N NOESY |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 7 |
3D 1H-13C NOESY |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 8 |
3D 1H-13C_arom NOESY |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 9 |
2D 1H-15 HSQC (IPAP) |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 10 |
2D 1H-15N HSQC |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 11 |
2D 1H-13C Constant Time HSQC |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 12 |
3D HBHA(CO)NH |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |
| 13 |
3D HNCO (IPAP) |
0.5 mM [U-13C; U-15N] ubiquilin 1, 10 mM TRIS, 300 mM sodium chloride (NaCl), 0.01 % sodium azide (NaN3), 1 x inhibitor cocktail (roche), 1 mM benzamidine, 10 uM ZnSO4, 10 mM DTT, 10 % D20, 90 % H20, 90% H2O/10% D2O |
300 |
90% H2O/10% D2O |
7.0 |
ambient |
298 |